Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-24

Clinical Trial Update: Bioequivalence of a Diabetes Specific Tube Feed [NA]

View source ↗

Summary

This completed clinical trial assesses the bioequivalence of a diabetes-specific enteral tube feed, with postprandial glucose response as the measured outcome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diabetes-Specific Enteral Tube Feed

Snippet

Sponsor: Nutricia Research | Conditions: Postprandial Glucose Response | NA | Status: COMPLETED